In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss

J. Hilderink; H.F.J.M. Koopman; F. Wolbers; J.S. Kanger; E. Ferlemann; J.F.J. Engbersen; M. Bronsema; A.A. Poot; H.R. Franke; I. Vermes

In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss

J. Hilderink, H.F.J.M. Koopman (Editor), F. Wolbers, J.S. Kanger (Editor), E. Ferlemann, J.F.J. Engbersen (Editor), M. Bronsema, A.A. Poot, H.R. Franke, I. Vermes

Research output: Contribution to conference › Paper

Original language	English
Pages	90-92
Publication status	Published - 20 Nov 2008
Event	Symposium Highlights in Biomedical Technology 2008 - University of Twente, Enschede, Netherlands Duration: 20 Nov 2008 → 20 Nov 2008

Other

Other	Symposium Highlights in Biomedical Technology 2008
Country/Territory	Netherlands
City	Enschede
Period	20/11/08 → 20/11/08

Keywords

METIS-255694

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hilderink, J., Koopman, H. F. J. M. (Ed.), Wolbers, F., Kanger, J. S. (Ed.), Ferlemann, E., Engbersen, J. F. J. (Ed.), Bronsema, M., Poot, A. A., Franke, H. R., & Vermes, I. (2008). In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss. 90-92. Paper presented at Symposium Highlights in Biomedical Technology 2008, Enschede, Netherlands.

@conference{f4ebd094c94f4265a3edbaf97e0684fe,

title = "In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss",

keywords = "METIS-255694",

author = "J. Hilderink and H.F.J.M. Koopman and F. Wolbers and J.S. Kanger and E. Ferlemann and J.F.J. Engbersen and M. Bronsema and A.A. Poot and H.R. Franke and I. Vermes",

note = "BMTI/IBME symposium t.g.v. afscheid Prof. Dr J. Feijen ; Symposium Highlights in Biomedical Technology 2008 ; Conference date: 20-11-2008 Through 20-11-2008",

year = "2008",

month = nov,

day = "20",

language = "English",

pages = "90--92",

}

Hilderink, J, Koopman, HFJM (ed.), Wolbers, F, Kanger, JS (ed.), Ferlemann, E, Engbersen, JFJ (ed.), Bronsema, M, Poot, AA, Franke, HR & Vermes, I 2008, 'In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss', Paper presented at Symposium Highlights in Biomedical Technology 2008, Enschede, Netherlands, 20/11/08 - 20/11/08 pp. 90-92.

In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss. / Hilderink, J.; Koopman, H.F.J.M. (Editor); Wolbers, F. et al.
2008. 90-92 Paper presented at Symposium Highlights in Biomedical Technology 2008, Enschede, Netherlands.

Research output: Contribution to conference › Paper

TY - CONF

T1 - In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss

AU - Hilderink, J.

AU - Wolbers, F.

AU - Ferlemann, E.

AU - Bronsema, M.

AU - Poot, A.A.

AU - Franke, H.R.

AU - Vermes, I.

A2 - Koopman, H.F.J.M.

A2 - Kanger, J.S.

A2 - Engbersen, J.F.J.

N1 - BMTI/IBME symposium t.g.v. afscheid Prof. Dr J. Feijen

PY - 2008/11/20

Y1 - 2008/11/20

KW - METIS-255694

M3 - Paper

SP - 90

EP - 92

T2 - Symposium Highlights in Biomedical Technology 2008

Y2 - 20 November 2008 through 20 November 2008

ER -

Hilderink J, Koopman HFJM, (ed.), Wolbers F, Kanger JS, (ed.), Ferlemann E, Engbersen JFJ, (ed.) et al.. In vitro study to analyse the singel and combined administration of aromatase inhibitors with bisphosphonates to improve the current hormonal breast cancer therapy and prevend bone loss. 2008. Paper presented at Symposium Highlights in Biomedical Technology 2008, Enschede, Netherlands.